___

• [1] Zhou DD, Wang W, Wang GM, et al. An updated metaanalysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessivecompulsive disorder. J Affect Disord 2017; 215:187-196. https://doi.org/10.1016/j.jad.2017.03.033
• [2] Van Ameringen M, Patterson B, Simpson W. DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria. Depress Anxiety 2014; 31: 487-93. https://doi.org/10.1002/da.22259
• [3] Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessivecompulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry 2008; 9(4):248-312. https:// doi.org/10.1080/15622970802465807
• [4] Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, posttraumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol 2014; 28(5):403-439. https://doi. org/10.1177/0269881114525674
• [5] Stein DJ, Koen N, Fineberg N, et al. A 2012 evidencebased algorithm for the pharmacotherapy for obsessivecompulsive disorder. Curr Psychiatry Rep. 2012;14(3):211- 9. https://doi.org/10.1007/s11920-012-0268-9
• [6] Jaafari N, Rachid F, Rotge JY, et al. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: a review. World J Biol Psychiatry 2012; 13(3):164-177. https://doi.or g/10.3109/15622975.2011.575177
• [7] Tolin D, Abramowitz J, Diefenbach G. Defining response in clinical trials for obsessive compulsive disorder: A signal detection analysis of the Yale-Brown Obsessive Compulsive Scale. J Clin Psychiatry. 2005;66(12):1549- 1557. https://doi.org/10.4088/JCP.v66n1209
• [8] Walsh KH, McDougle CJ. Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder. Expert Opin Pharmacother 2004;5:2059-67. https://doi.org/10.1517/14656566.5.10.2059
• [9] Pallanti S, Hollander E, Goodman WK. A qualitative analysis of non-response: Management of treatmentrefractory obsessive-compulsive disorder. J Clin Psychiatry 2004;65:6-10. https://doi.org/10.4088/JCP.v65n1015
• [10] Pallanti S, Hollander E, Bienstock C, et al. Treatment nonresponse in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol. 2002;5(2):181- 91. https://doi.org/10.1017/S1461145702002900
• [11] Rauch SL, Jenike MA. Management of treatment resistant obsessive-compulsive disorder: concepts and strategies. In: Hollander E, Zohar J, Marazziti D, Olivier B, editors. Obsessive compulsive disorder. Chicester: Wiley. 1994; p: 227-44.
• [12] Del Casale A, Sorice S, Padovano A, et al. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Curr Neuropharmacol 2019; 17(8):710-736. https://doi. org/10.2174/1570159X16666180813155017
• [13] Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 2012; 16(1):43-51. https://doi.org/10.1016/j. tics.2011.11.003
• [14] Del Casale A, Kotzalidis GD, Rapinesi C, et al. Functional neuroimaging in obsessive-compulsive disorder. Neuropsychobiology 2011; 64(2):61-85. https://doi. org/10.1159/000325223
• [15] Perera T, George MS, Grammer G, et al. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul 2016; 9(3):336-346. https://doi. org/10.1016/j.brs.2016.03.010
• [16] Trevizol AP, Shiozawa P, Cook IA, et al. Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis. J ECT 2016; 32(4):262-266. https://doi.org/10.1097/ YCT.0000000000000335
• [17] Singh S, Kumar S, Gupta A, et al. Effectiveness and Predictors of Response to 1-Hz Repetitive Transcranial Magnetic Stimulation in Patients With Obsessive- Compulsive Disorder. J ECT 2019; 35(1):61-66. https://doi. org/10.1097/YCT.0000000000000530
• [18] Kumar S, Kumar N, Verma R. Safety and efficacy of adjunctive transcranial direct current stimulation in treatmentresistant obsessive-compulsive disorder: An open-label trial. Indian J Psychiatry 2019; 61(4):327-334. https://doi. org/10.4103/psychiatry.IndianJPsychiatry_509_18
• [19] Cocchi L, Zalesky A, Nott Z, et al. Transcranial magnetic stimulation in obsessive-compulsive disorder: A focus on network mechanisms and state dependence. Neuroimage Clin 2018; 19:661-674. https://doi.org/10.1016/j. nicl.2018.05.029
• [20] Paus, T., Castro Alamancos, M.A., Petrides, M., 2001. Corticocortical connectivity of the human mid dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur. J. Neurosci 14, 1405-1411. https://doi.org/10.1046/j.0953-816x.2001.01757.x
• [21] Saba G, Moukheiber A, Pelissolo A. Transcranial cortical stimulation in the treatment of obsessivecompulsive disorders: efficacy studies. Curr Psychiatry Rep. 2015;17(5):1-8. https://doi.org/10.1007/s11920-015-0571- 3
• [22] Greenberg BD, George MS, Martin JD, et al. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry 1997; 154(6):867-869. https://doi.org/10.1176/ ajp.154.6.867
• [23] Sachdev PS, McBride R, Loo CK, et al. Right versus left prefrontal transcranial magnetic stimulation for obsessivecompulsive disorder: a preliminary investigation. J Clin Psychiatry 2001; 62(12):981-984. https://doi.org/10.4088/ JCP.v62n1211
• [24] Berlim MT, Neufeld NH, Van den Eynde F. Repetitive transcranial magnetic stimulation (rTMS) for obsessivecompulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res 2013; 47(8):999-1006. https://doi.org/10.1016/j. jpsychires.2013.03.022
• [25] Rossi S, Hallett M, Rossini PM, et al. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120(12):2008-2039. https://doi.org/10.1016/j. clinph.2009.08.016
• [26] Rothwell JC, Hallett M, Berardelli A, et al. Magnetic stimulation: motor evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalography and clinical neurophysiology 1999; 52:97-103.
• [27] Herwig U, Padberg F, Unger J, et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry 2001; 50(1):58-61. https://doi.org/10.1016/ S0006-3223(01)01153-2
• [28] Goodman WK, Price LH, Rasmussen SA, et al. The Yale- Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46(11):1006-1011. https://doi.org/10.1001/archpsyc.1989.01810110048007
• [29] Cocchi L, Zalesky A. Personalized transcranial magnetic stimulation in psychiatry. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2018; 3(9):731-741. https://doi.org/10.1016/j.bpsc.2018.01.008
• [30] Rehn S, Eslick GD, Brakoulias V. A meta-analysis of the effectiveness of different cortical targets used in repetitive transcranial magnetic stimulation (rTMS) for the treatment of obsessive-compulsive disorder (OCD). Psychiatric Quarterly 2018; 89(3): 645-665. https://doi.org/10.1007/ s11126-018-9566-7
• [31] Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clin. Neurophysiol. 2020; 131: 474-528. https://doi. org/10.1016/j.clinph.2019.11.002
• [32] Sachdev PS, Loo CK, Mitchell PB, et al. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation. Psychol Med 2007; 37(11):1645-1649. https://doi.org/10.1017/S0033291707001092
• [33] Mansur CG, Myczkowki ML, de Barros Cabral S, et al. Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial. Int J Neuropsychopharmacol 2011; 14(10):1389-1397. https://doi.org/10.1017/ S1461145711000575
• [34] Alonso P, Pujol J, Cardoner N, et al. Right prefrontal repetitive transcranial magnetic stimulation in obsessivecompulsive disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2001; 158(7):1143-1145. https://doi. org/10.1176/appi.ajp.158.7.1143
• [35] Prasko J, Pasková B, Záleský R, et al. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham-controlled study. Neuro Endocrinol Lett 2006; 27(3):327-332.
• [36] Liang K, Li H, Bu X, et al. Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Translational psychiatry. 2021; 11(1): 1-10. https://doi.org/10.1038/ s41398-021-01453-0
• [37] Haghighi M, Shayganfard M, Jahangard L, et al. Repetitive Transcranial Magnetic Stimulation (rTMS) improves symptoms and reduces clinical illness in patients suffering from OCD--Results from a single-blind, randomized clinical trial with sham cross-over condition. J Psychiatr Res 2015; 68:238-244. https://doi.org/10.1016/j. jpsychires.2015.06.020
• [38] Angst J, Gamma A, Endrass J, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci. 2004;2543):156-64. https://doi.org/10.1007/s00406-004- 0459-4
• [39] Mantovani A, Simpson HB, Fallon BA, Rossi S, Lisanby SH. Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatmentresistant obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2010;13(2):217-27. https://doi. org/10.1017/S1461145709990435
• [40] Ma X, Huang Y, Liao L, et al. A randomized doubleblinded sham-controlled trial of electroencephalogramguided transcranial magnetic stimulation for obsessivecompulsive disorder. Chinese Medical Journal. 2014; 127(04): 601-606.
• [41] Perera MPN, Mallawaarachchi S, Miljevic A, et al. Repetitive Transcranial Magnetic Stimulation for Obsessive- Compulsive Disorder: A Meta-analysis of Randomized, Sham-Controlled Trials. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2021; 6(10): 947-960. https://doi.org/10.1016/j.bpsc.2021.03.010
• [42] Ma ZR, Shi LJ. (2014). Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessivecompulsive disorder (OCD): a meta-analysis of randomized controlled trials. International Journal of Clinical and Experimental Medicine, 7(12), 4897.
• [43] Hett D, Rogers J, Humpston C, et al. Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in adolescence: a systematic review. Journal of Affective Disorders. 2021; 278: 460-469. https://doi. org/10.1016/j.jad.2020.09.058